MD4434C1 - Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor - Google Patents

Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor

Info

Publication number
MD4434C1
MD4434C1 MDA20150097A MD20150097A MD4434C1 MD 4434 C1 MD4434 C1 MD 4434C1 MD A20150097 A MDA20150097 A MD A20150097A MD 20150097 A MD20150097 A MD 20150097A MD 4434 C1 MD4434 C1 MD 4434C1
Authority
MD
Moldova
Prior art keywords
myeloid leukemia
cell proliferation
human myeloid
carbothiohydrazide
morpholin
Prior art date
Application number
MDA20150097A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD4434B1 (en
Inventor
Анастасия ПАХОЛНИЦКАЯ
Дональд ПОЙРИЕР
Виктор ЦАПКОВ
Аурелиан ГУЛЯ
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20150097A priority Critical patent/MD4434C1/en
Publication of MD4434B1 publication Critical patent/MD4434B1/en
Publication of MD4434C1 publication Critical patent/MD4434C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to chemistry and medicine, namely to the use of an organic compound from the class of thiosemicarbazones as a human myeloid leukemia HL-60 cell proliferation inhibitor and can be used in medicine in the prevention and treatment of leukoses.Summary of the invention consists in the use as a human myeloid leukemia HL-60 cell proliferation inhibitor of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide of formula:This compound has a significant cytostatic activity, inclusively at a concentration of 10-7 mol/L, with respect to human myeloid leukemia HL-60 cells.
MDA20150097A 2015-10-09 2015-10-09 Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor MD4434C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20150097A MD4434C1 (en) 2015-10-09 2015-10-09 Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20150097A MD4434C1 (en) 2015-10-09 2015-10-09 Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor

Publications (2)

Publication Number Publication Date
MD4434B1 MD4434B1 (en) 2016-09-30
MD4434C1 true MD4434C1 (en) 2017-04-30

Family

ID=57014936

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20150097A MD4434C1 (en) 2015-10-09 2015-10-09 Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor

Country Status (1)

Country Link
MD (1) MD4434C1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000955A1 (en) * 1983-08-22 1985-03-14 A/S Cheminova A biocidal, particularly fungicidal and/or bactericidal composition and thiosemicarbazones and metal complexes thereof for use in the composition
US4596798A (en) * 1982-03-30 1986-06-24 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazones as antiviral agents
US5281715A (en) * 1992-05-13 1994-01-25 Yale University 2-formylpyridine thiosemicarbazone compounds
US20030166658A1 (en) * 2000-06-05 2003-09-04 Johann Hofmann Heterocyclic hydrazones for use as anti-cancer agents
MD3890G2 (en) * 2008-09-08 2009-12-31 Государственный Университет Молд0 Inhibitors of human myeloid leukemia on base of coordinative compounds of copper(II) with salicylidene thiocarbazides
MD20110040A1 (en) * 2011-05-10 2012-11-30 Государственный Университет Молд0 Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate
MD4215C1 (en) * 2012-07-09 2013-11-30 Государственный Университет Молд0 Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide
MD4393B1 (en) * 2015-09-04 2016-01-31 Universitatea De Stat Din Moldova Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper
MD4407B1 (en) * 2015-04-29 2016-03-31 Universitatea De Stat Din Moldova Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596798A (en) * 1982-03-30 1986-06-24 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazones as antiviral agents
WO1985000955A1 (en) * 1983-08-22 1985-03-14 A/S Cheminova A biocidal, particularly fungicidal and/or bactericidal composition and thiosemicarbazones and metal complexes thereof for use in the composition
US5281715A (en) * 1992-05-13 1994-01-25 Yale University 2-formylpyridine thiosemicarbazone compounds
US5721259A (en) * 1992-05-13 1998-02-24 Yale University Method of using 2-formylpyridine thiosemicarbazone compounds
US20030166658A1 (en) * 2000-06-05 2003-09-04 Johann Hofmann Heterocyclic hydrazones for use as anti-cancer agents
MD3890G2 (en) * 2008-09-08 2009-12-31 Государственный Университет Молд0 Inhibitors of human myeloid leukemia on base of coordinative compounds of copper(II) with salicylidene thiocarbazides
MD20110040A1 (en) * 2011-05-10 2012-11-30 Государственный Университет Молд0 Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate
MD4215C1 (en) * 2012-07-09 2013-11-30 Государственный Университет Молд0 Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide
MD4407B1 (en) * 2015-04-29 2016-03-31 Universitatea De Stat Din Moldova Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate
MD4393B1 (en) * 2015-09-04 2016-01-31 Universitatea De Stat Din Moldova Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Amandha KAISER DA SILVA. Complexos Heterolepticos de Ouro(III) como Potenciais Antitumorais e Anti-Trypanosoma cruzi// Dissertacao apresentada ao Instituto de Quimica de Sao Carlos. P. 31 // Sao Carlos, 2015, Data publicare: 2015-05-22, regasit la 2016.07.18, url: http://www.teses.usp.br/teses/disponiveis/75/75135/tde-20052015-154103/publico/AmandhaKaiserdaSilvarevisado.pdf pag. 31 *
ARORA Sh., AGARVAL Sh., SINGHAL Sh. Anticancer activities of thiosemicarbazides/thiosemicarbazones: a Review. Int. J. Pharmacy and Pharmaceutical sciences, vol. 6, Issuie 9, 2014. Regăsit în Internet la 2016.07.21, url: http://innovareacademics.in/journals/index.php/ijpps/article/view/1837 pag.1-2 *
D.KOVALA-DEMERTZI et al. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopical study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents. Eur. J. Med. Chem., v. 44, p. 1296-1302, 2009. Regăsit în Internet la 2016.07.20, url: https://www.researchgate.net/profile/Alexandros_Alexandratos2/publication/230792819_In_vitro_and_in_vivo_antitumor_activity_of_platinum(II)_complexes_withthiosemicarbazones_derived_from_2-formyl_and_2-acetyl_pyridine_andcontaining_ring_incorporated_at_N(4)-position_Synthesis_spectroscopicstudy_and_crystal_structure_of_platinum(II)_complexes_with_thiosemicarbazonespotential_anticancer_agents/links/0912f504724d66065a000000.pdf pag.1299, Table 4, compound (2). *
Kasuga N.C., Onodera K., Nakano S., Hazashi K., Nomiya K. Synthesis, crystal structures and antimicrobial activities of 6-coordinate antimony(III) complexes with tridentate 2-acetylpyridine thiosemicarbazone, bis(thiosemicarbazone) and semicarbazone ligands. J. Inorg. Biochem. 2006 July, 100, p. 1176-1186 DOI: 10.1016/j.inorbio.2006.01.037 *
Serda M. et al. (2014) Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships. PLOS ONE 9(10): e110291. doi: 10.1371/journal.pone.0110291. Published October 16, 2014. Regăsit în Internet la 2016.07.18 url: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110291 page 6 Figure5, chelator 1c; pag. 7 Table 1, chelator 1c *

Also Published As

Publication number Publication date
MD4434B1 (en) 2016-09-30

Similar Documents

Publication Publication Date Title
MX2017009571A (en) Heterocyclic itk inhibitors for treating inflammation and cancer.
PH12017500367B1 (en) Compounds that inhibit mcl-1 protein
CY1120318T1 (en) Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients
BR112016002496A2 (en) compound of formula i, pharmaceutical composition, method for inhibiting kdm1a, method for treating a globin-mediated disease, method for achieving an effect on a patient, and method for inhibiting at least one function of kdm1a
MX2020007485A (en) Antiproliferative compounds and methods of use thereof.
SA519401970B1 (en) Heterocyclic inhibitors of monocarboxylate transporter 4
TR201904614T4 (en) Novel pyrazole derivative.
MX2017016325A (en) Brk inhibitory compound.
MY162146A (en) Pharmaceutical composition
WO2017087808A8 (en) Heterocyclic compounds that inhibit the kinase activity of mnk useful for treating various cancers
EA201100136A1 (en) 2,4'-BIPIRIDINILES AS PROTEINKINASE DIOR INHIBITORS APPLICABLE FOR THE TREATMENT OF HEART FAILURE AND CANCER
EA201591781A1 (en) CHEMICAL COMPOUNDS
PH12016502130A1 (en) Novel pyrrolopyrimidine compound or salt thereof, pharmaceutical composition containing same, especially agent for prevention and/or treatment of tumors etc based on nae inhibitory effect
MX359656B (en) Oxoquinazolinyl-butanamide derivatives.
MX2014005895A (en) Medicine for treatment and/or improvement of sepsis.
MX364859B (en) Imidazopyrazinone derivatives.
MX2016001536A (en) Piperidine urea derivatives.
MD4215B1 (en) Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide
AU2017258649A1 (en) Covalent BTK inhibitors and uses thereof
MX2019006749A (en) Cellular senescence activating compounds.
MX2020011002A (en) Combination comprising hdac inhibitor, lag-3 inhibitor and a pd-1 inhibitor or pd-l1 inhibitor for cancer treatment.
MD4434C1 (en) Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor
MX2021012499A (en) Improved inhibitors of the notch transcriptional activation complex and methods for use of the same.
MX369393B (en) Phthalazine derivatives.
MD4613B1 (en) Ethyl-4-{2-[(pyridin-2-ylmethylidene)hydrazinocarbothioyl]amino benzoate monohydrate exhibiting properties of human myeloid leukemia HL-60 cell proliferation inhibitor

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees